1 of 1
Story summary
- Professor Chloe Bloom and UK researchers reported semaglutide reduced asthma attacks by up to 40%.
- The analysis used electronic health records of 20,000 asthma and 22,000 COPD patients.
- Semaglutide lowered COPD exacerbations by up to 20%, with higher doses showing stronger reductions.
- Researchers warned the findings should not alter treatment guidelines, urging clinical trials.
